Cash Flow Statement
Growth Metrics

Xtant Medical Holdings (XTNT) Cash from Investing Activities Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -4,224.26%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 95.53%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 3.20%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -18.20%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -208.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -187.82%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -397.90%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -514.25%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -211.17%
10 Xtant Medical Holdings 64.46 Mn 47.14 Mn 17.75 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 332.90%
Jun 30, 2025 33.96%
Mar 31, 2025 -69.58%
Dec 31, 2024 75.49%
Sep 30, 2024 56.85%
Jun 30, 2024 -21.83%
Mar 31, 2024 96.13%
Dec 31, 2023 -448.10%
Sep 30, 2023 -846.34%
Jun 30, 2023 -55.12%
Mar 31, 2023 -4,355.50%
Dec 31, 2022 29.08%
Sep 30, 2022 -44.28%
Jun 30, 2022 46.07%
Mar 31, 2022 19.05%
Dec 31, 2021 -4.39%
Sep 30, 2021 -104.19%
Jun 30, 2021 -20.15%
Mar 31, 2021 -176.00%
Dec 31, 2020 -49.21%
Sep 30, 2020 -46.49%
Jun 30, 2020 -1,131.58%
Mar 31, 2020 -103.49%
Dec 31, 2019 -23.23%
Sep 30, 2019 -149.35%
Jun 30, 2019 124.36%
Mar 31, 2019 34.85%
Dec 31, 2018 -103.95%
Sep 30, 2018 159.54%
Jun 30, 2018 79.42%
Mar 31, 2018 57.42%
Dec 31, 2017 42.88%
Sep 30, 2017 67.14%
Jun 30, 2017 54.08%
Mar 31, 2017 88.60%
Dec 31, 2016 -35.59%
Sep 30, 2016 98.39%
Jun 30, 2016 -7,515.82%
Mar 31, 2016 -8,304.12%
Dec 31, 2015 -66.47%
Sep 30, 2015 -72,264.81%
Jun 30, 2015 64.04%
Mar 31, 2015 -71.54%
Dec 31, 2014 -136.95%
Sep 30, 2014 -89.48%
Jun 30, 2014 46.30%
Mar 31, 2014 96.05%
Dec 31, 2013 91.98%
Sep 30, 2013 84.55%
Jun 30, 2013 78.54%
Mar 31, 2013 -37.44%
Dec 31, 2012 -48.24%
Sep 30, 2012 -56.27%
Jun 30, 2012 -243.94%
Mar 31, 2012 -54.17%
Dec 31, 2011 -8.92%
Sep 30, 2011 22.69%